{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T08:12:56Z","timestamp":1778227976906,"version":"3.51.4"},"reference-count":106,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","theclinics.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Surgical Clinics of North America"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.suc.2024.02.016","type":"journal-article","created":{"date-parts":[[2024,4,4]],"date-time":"2024-04-04T04:17:08Z","timestamp":1712204228000},"page":"909-928","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Evaluation and Surgical Management of Multiple Endocrine Neoplasias"],"prefix":"10.1016","volume":"104","author":[{"given":"C. Corbin","family":"Frye","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taylor C.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr.","given":"John A.","family":"Olson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.suc.2024.02.016_bib1","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1111\/imj.14394","article-title":"Multiple endocrine neoplasia: an update","volume":"49","author":"McDonnell","year":"2019","journal-title":"Intern Med J"},{"issue":"2","key":"10.1016\/j.suc.2024.02.016_bib2","doi-asserted-by":"crossref","DOI":"10.1530\/EC-22-0411","article-title":"Multiple endocrine neoplasia type 4: a new member of the MEN family","volume":"12","author":"Singeisen","year":"2023","journal-title":"Endocr Connect"},{"issue":"6","key":"10.1016\/j.suc.2024.02.016_bib3","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1046\/j.1365-2796.1998.00345.x","article-title":"Familial multiple endocrine neoplasia syndromes: components, classification, and nomenclature","volume":"243","author":"Carney","year":"1998","journal-title":"J\u00a0Intern Med"},{"issue":"9","key":"10.1016\/j.suc.2024.02.016_bib4","doi-asserted-by":"crossref","first-page":"2990","DOI":"10.1210\/jc.2012-1230","article-title":"Clinical Practice Guidelines for Multiple Endocrine Neoplasia Type 1 (MEN1)","volume":"97","author":"Thakker","year":"2012","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.suc.2024.02.016_bib5","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/s41574-021-00468-3","article-title":"Clinical aspects of multiple endocrine neoplasia type 1","volume":"17","author":"Al-Salameh","year":"2021","journal-title":"Nat Rev Endocrinol"},{"issue":"5311","key":"10.1016\/j.suc.2024.02.016_bib6","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1126\/science.276.5311.404","article-title":"Positional cloning of the gene for multiple endocrine neoplasia-type 1","volume":"276","author":"Chandrasekharappa","year":"1997","journal-title":"Science"},{"issue":"8","key":"10.1016\/j.suc.2024.02.016_bib7","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.tibs.2013.05.005","article-title":"Menin: a scaffold protein that controls gene expression and cell signaling","volume":"38","author":"Matkar","year":"2013","journal-title":"Trends Biochem Sci"},{"issue":"9","key":"10.1016\/j.suc.2024.02.016_bib8","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1093\/qjmed\/89.9.653","article-title":"Clinical studies of multiple endocrine neoplasia type 1 (MEN1)","volume":"89","author":"Trump","year":"1996","journal-title":"QJM Mon J Assoc Physicians"},{"key":"10.1016\/j.suc.2024.02.016_bib9","series-title":"Surgery of the thyroid and parathyroid gland","first-page":"576","article-title":"Parathyroid management in the MEN syndromes","author":"Wang","year":"2020"},{"issue":"Suppl 1","key":"10.1016\/j.suc.2024.02.016_bib10","doi-asserted-by":"crossref","first-page":"99","DOI":"10.6061\/clinics\/2012(Sup01)17","article-title":"Biochemical, bone and renal patterns in hyperparathyroidism associated with multiple endocrine neoplasia type 1","volume":"67","author":"Louren\u00e7o","year":"2012","journal-title":"Clin Sao Paulo Braz"},{"issue":"6","key":"10.1016\/j.suc.2024.02.016_bib11","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/S0039-6060(03)00406-9","article-title":"Results of initial operation for hyperparathyroidism in patients with multiple endocrine neoplasia type 1","volume":"134","author":"Elaraj","year":"2003","journal-title":"Surgery"},{"issue":"3","key":"10.1016\/j.suc.2024.02.016_bib12","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1097\/SLA.0000000000000207","article-title":"PREDICTORS OF RECURRENCE IN PRIMARY HYPERPARATHYROIDISM: AN ANALYSIS OF 1,386 CASES","volume":"259","author":"Schneider","year":"2014","journal-title":"Ann Surg"},{"issue":"3","key":"10.1016\/j.suc.2024.02.016_bib13","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1097\/SLA.0b013e31815efda5","article-title":"Prospective study of surgery for primary hyperparathyroidism (HPT) in multiple endocrine neoplasia-type 1 and Zollinger-Ellison syndrome: long-term outcome of a more virulent form of HPT","volume":"247","author":"Norton","year":"2008","journal-title":"Ann Surg"},{"issue":"4","key":"10.1016\/j.suc.2024.02.016_bib14","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1001\/archsurg.140.4.374","article-title":"Surgical treatment of hyperparathyroidism in patients with multiple endocrine neoplasia type 1","volume":"140","author":"Lambert","year":"2005","journal-title":"Arch Surg"},{"issue":"7","key":"10.1016\/j.suc.2024.02.016_bib15","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1507\/endocrj.K09E-204","article-title":"Surgical approach in hereditary hyperparathyroidism","volume":"56","author":"Tonelli","year":"2009","journal-title":"Endocr J"},{"key":"10.1016\/j.suc.2024.02.016_bib16","first-page":"1","article-title":"Preoperative thyroid ultrasound is indicated in patients undergoing parathyroidectomy for primary hyperparathyroidism","volume":"3","author":"Arciero","year":"2012","journal-title":"J\u00a0Cancer"},{"issue":"10","key":"10.1016\/j.suc.2024.02.016_bib17","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1001\/jamasurg.2016.2310","article-title":"The American Association of Endocrine Surgeons Guidelines for Definitive Management of Primary Hyperparathyroidism","volume":"151","author":"Wilhelm","year":"2016","journal-title":"JAMA Surg"},{"issue":"11","key":"10.1016\/j.suc.2024.02.016_bib18","doi-asserted-by":"crossref","first-page":"2234","DOI":"10.1007\/s00268-009-9924-6","article-title":"Familial parathyroid tumors: diagnosis and management","volume":"33","author":"St\u00e5lberg","year":"2009","journal-title":"World J Surg"},{"issue":"12","key":"10.1016\/j.suc.2024.02.016_bib19","doi-asserted-by":"crossref","first-page":"2964","DOI":"10.1007\/s00268-016-3624-9","article-title":"Unilateral Clearance for Primary Hyperparathyroidism in Selected Patients with Multiple Endocrine Neoplasia Type 1","volume":"40","author":"Kluijfhout","year":"2016","journal-title":"World J Surg"},{"issue":"1","key":"10.1016\/j.suc.2024.02.016_bib20","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/cen.14112","article-title":"Single gland excision for MEN1-associated primary hyperparathyroidism","volume":"92","author":"Manoharan","year":"2020","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.suc.2024.02.016_bib21","doi-asserted-by":"crossref","first-page":"123","DOI":"10.3389\/fendo.2019.00123","article-title":"Could the Less-Than Subtotal Parathyroidectomy Be an Option for Treating Young Patients With Multiple Endocrine Neoplasia Type 1-Related Hyperparathyroidism?","volume":"10","author":"Montenegro","year":"2019","journal-title":"Front Endocrinol"},{"issue":"2","key":"10.1016\/j.suc.2024.02.016_bib22","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1245\/s10434-015-4865-9","article-title":"Limited Parathyroidectomy in Multiple Endocrine Neoplasia Type 1-Associated Primary Hyperparathyroidism: A Setup for Failure","volume":"23","author":"Nilubol","year":"2016","journal-title":"Ann Surg Oncol"},{"issue":"7","key":"10.1016\/j.suc.2024.02.016_bib23","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1007\/s00268-001-0046-z","article-title":"Hyperparathyroidism in multiple endocrine neoplasia type I: surgical trends and results of a 256-patient series from Groupe D\u2019etude des N\u00e9oplasies Endocriniennes Multiples Study Group","volume":"25","author":"Goudet","year":"2001","journal-title":"World J Surg"},{"issue":"3","key":"10.1016\/j.suc.2024.02.016_bib24","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1001\/archsurg.141.3.235","article-title":"Subtotal parathyroidectomy as an adequate treatment for primary hyperparathyroidism in multiple endocrine neoplasia type 1","volume":"141","author":"Hubbard","year":"2006","journal-title":"Arch Surg"},{"issue":"6","key":"10.1016\/j.suc.2024.02.016_bib25","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1016\/j.surg.2014.08.006","article-title":"A\u00a0randomized, prospective trial of operative treatments for hyperparathyroidism in patients with multiple endocrine neoplasia type 1","volume":"156","author":"Lairmore","year":"2014","journal-title":"Surgery"},{"issue":"4","key":"10.1016\/j.suc.2024.02.016_bib26","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1007\/s11864-006-0042-5","article-title":"Surgical approach to the patient with familial hyperparathyroidism","volume":"7","author":"VanderWalde","year":"2006","journal-title":"Curr Treat Options Oncol"},{"issue":"6","key":"10.1016\/j.suc.2024.02.016_bib27","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1097\/SLA.0b013e31824c5145","article-title":"Primary hyperparathyroidism in MEN1 patients: a cohort study with longterm follow-up on preferred surgical procedure and the relation with genotype","volume":"255","author":"Pieterman","year":"2012","journal-title":"Ann Surg"},{"key":"10.1016\/j.suc.2024.02.016_bib28","doi-asserted-by":"crossref","first-page":"618","DOI":"10.3389\/fendo.2018.00618","article-title":"Intraoperative Decision-Making and Technical Aspects of Parathyroidectomy in Young Patients With MEN1 Related Hyperparathyroidism","volume":"9","author":"Nobecourt","year":"2018","journal-title":"Front Endocrinol"},{"issue":"6","key":"10.1016\/j.suc.2024.02.016_bib29","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1007\/s00268-010-0605-2","article-title":"Causes and treatment of recurrent hyperparathyroidism after subtotal parathyroidectomy in the presence of multiple endocrine neoplasia 1","volume":"34","author":"Salmeron","year":"2010","journal-title":"World J Surg"},{"issue":"6","key":"10.1016\/j.suc.2024.02.016_bib30","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/j.surg.2008.08.031","article-title":"The utility of routine transcervical thymectomy for multiple endocrine neoplasia 1-related hyperparathyroidism","volume":"144","author":"Powell","year":"2008","journal-title":"Surgery"},{"issue":"2","key":"10.1016\/j.suc.2024.02.016_bib31","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s00268-009-0290-1","article-title":"Risk factors and causes of death in MEN1 disease. A GTE (Groupe d\u2019Etude des Tumeurs Endocrines) cohort study among 758 patients","volume":"34","author":"Goudet","year":"2010","journal-title":"World J Surg"},{"issue":"1","key":"10.1016\/j.suc.2024.02.016_bib32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/thy.2015.0020","article-title":"2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer","volume":"26","author":"Haugen","year":"2016","journal-title":"Thyroid Off J Am Thyroid Assoc"},{"issue":"4","key":"10.1016\/j.suc.2024.02.016_bib33","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1097\/00000658-198010000-00003","article-title":"Long-term evaluation of patients with primary parathyroid hyperplasia managed by total parathyroidectomy and heterotopic autotransplantation","volume":"192","author":"Wells","year":"1980","journal-title":"Ann Surg"},{"issue":"6","key":"10.1016\/j.suc.2024.02.016_bib34","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1067\/msy.1998.93107","article-title":"The variable penetrance and spectrum of manifestations of multiple endocrine neoplasia type 1","volume":"124","author":"Carty","year":"1998","journal-title":"Surgery"},{"issue":"2","key":"10.1016\/j.suc.2024.02.016_bib35","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1097\/01.sla.0000197715.96762.68","article-title":"Epidemiology data on 108 MEN 1 patients from the GTE with isolated nonfunctioning tumors of the pancreas","volume":"243","author":"Triponez","year":"2006","journal-title":"Ann Surg"},{"issue":"1","key":"10.1016\/j.suc.2024.02.016_bib36","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1530\/EJE-10-0950","article-title":"Gender-related differences in MEN1 lesion occurrence and diagnosis: a cohort study of 734 cases from the Groupe d\u2019etude des Tumeurs Endocrines","volume":"165","author":"Goudet","year":"2011","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"10.1016\/j.suc.2024.02.016_bib37","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/cen.13264","article-title":"Long-term outcomes in patients with multiple endocrine neoplasia type 1 and pancreaticoduodenal neuroendocrine tumours","volume":"86","author":"Donegan","year":"2017","journal-title":"Clin Endocrinol"},{"issue":"6","key":"10.1016\/j.suc.2024.02.016_bib38","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/s002689900438","article-title":"Lethality of multiple endocrine neoplasia type I","volume":"22","author":"Doherty","year":"1998","journal-title":"World J Surg"},{"issue":"1","key":"10.1016\/j.suc.2024.02.016_bib39","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1097\/01.md.0000112297.72510.32","article-title":"Multiple endocrine neoplasia type 1 and Zollinger-Ellison syndrome: a prospective study of 107 cases and comparison with 1009 cases from the literature","volume":"83","author":"Gibril","year":"2004","journal-title":"Medicine (Baltim)"},{"issue":"2","key":"10.1016\/j.suc.2024.02.016_bib40","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1111\/j.1572-0241.2006.00367.x","article-title":"Prospective endoscopic ultrasonographic evaluation of the frequency of nonfunctioning pancreaticoduodenal endocrine tumors in patients with multiple endocrine neoplasia type 1","volume":"101","author":"Thomas-Marques","year":"2006","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"10.1016\/j.suc.2024.02.016_bib41","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.gie.2014.09.037","article-title":"EUS is superior for detection of pancreatic lesions compared with standard imaging in patients with multiple endocrine neoplasia type 1","volume":"81","author":"van Asselt","year":"2015","journal-title":"Gastrointest Endosc"},{"issue":"9","key":"10.1016\/j.suc.2024.02.016_bib42","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1210\/js.2018-00087","article-title":"Diagnosing Nonfunctional Pancreatic NETs in MEN1: The Evidence Base","volume":"2","author":"van Treijen","year":"2018","journal-title":"J\u00a0Endocr Soc"},{"issue":"3","key":"10.1016\/j.suc.2024.02.016_bib43","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1007\/s12020-015-0702-y","article-title":"Role of (68)Ga-DOTATATE PET\/CT in patients with multiple endocrine neoplasia type 1 (MEN1)","volume":"52","author":"Lastoria","year":"2016","journal-title":"Endocrine"},{"key":"10.1016\/j.suc.2024.02.016_bib44","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.654975","article-title":"The Impact of 68Gallium DOTA PET\/CT in Managing Patients With Sporadic and Familial Pancreatic Neuroendocrine Tumours","volume":"12","author":"Cuthbertson","year":"2021","journal-title":"Front Endocrinol"},{"issue":"6","key":"10.1016\/j.suc.2024.02.016_bib45","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1210\/jc.2016-3865","article-title":"Utility of FDG-PET Imaging for Risk Stratification of Pancreatic Neuroendocrine Tumors in MEN1","volume":"102","author":"Kornaczewski Jackson","year":"2017","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"11","key":"10.1016\/j.suc.2024.02.016_bib46","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1056\/NEJM199003153221103","article-title":"Gastrinomas in the duodenums of patients with multiple endocrine neoplasia type 1 and the Zollinger-Ellison syndrome","volume":"322","author":"Pipeleers-Marichal","year":"1990","journal-title":"N\u00a0Engl J Med"},{"issue":"6","key":"10.1016\/j.suc.2024.02.016_bib47","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1002\/1097-0142(19910915)68:6<1329::AID-CNCR2820680624>3.0.CO;2-7","article-title":"Surgical pathology of gastrinoma. Site, size, multicentricity, association with multiple endocrine neoplasia type 1, and malignancy","volume":"68","author":"Donow","year":"1991","journal-title":"Cancer"},{"issue":"6","key":"10.1016\/j.suc.2024.02.016_bib48","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/j.surg.2011.09.028","article-title":"Achieving eugastrinemia in MEN1 patients: both duodenal inspection and formal lymph node dissection are important","volume":"150","author":"Dickson","year":"2011","journal-title":"Surgery"},{"issue":"6","key":"10.1016\/j.suc.2024.02.016_bib49","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1097\/MPA.0b013e3181ebb168","article-title":"NANETS treatment guidelines: well-differentiated neuroendocrine tumors of the stomach and pancreas","volume":"39","author":"Kulke","year":"2010","journal-title":"Pancreas"},{"issue":"4","key":"10.1016\/j.suc.2024.02.016_bib50","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.suc.2019.04.015","article-title":"Surgical Management of Multiple Endocrine Neoplasia 1 and Multiple Endocrine Neoplasia 2","volume":"99","author":"Kiernan","year":"2019","journal-title":"Surg Clin North Am"},{"issue":"10","key":"10.1016\/j.suc.2024.02.016_bib51","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.3748\/wjg.v17.i10.1343","article-title":"Biochemically curative surgery for gastrinoma in multiple endocrine neoplasia type 1 patients","volume":"17","author":"Imamura","year":"2011","journal-title":"World J Gastroenterol"},{"issue":"2","key":"10.1016\/j.suc.2024.02.016_bib52","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1097\/SLA.0b013e3182536339","article-title":"Partial pancreaticoduodenectomy can provide cure for duodenal gastrinoma associated with multiple endocrine neoplasia type 1","volume":"257","author":"Lopez","year":"2013","journal-title":"Ann Surg"},{"issue":"3","key":"10.1016\/j.suc.2024.02.016_bib53","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1097\/01.sla.0000234802.44320.a5","article-title":"Surgery increases survival in patients with gastrinoma","volume":"244","author":"Norton","year":"2006","journal-title":"Ann Surg"},{"issue":"1","key":"10.1016\/j.suc.2024.02.016_bib54","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1097\/SLA.0000000000002191","article-title":"Long-term Follow-up of MEN1 Patients Who Do Not Have Initial Surgery for Small \u22642\u00a0cm Nonfunctioning Pancreatic Neuroendocrine Tumors, an AFCE and GTE Study: Association Francophone de Chirurgie Endocrinienne & Groupe d\u2019Etude des Tumeurs Endocrines","volume":"268","author":"Triponez","year":"2018","journal-title":"Ann Surg"},{"issue":"6","key":"10.1016\/j.suc.2024.02.016_bib55","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.surg.2007.09.010","article-title":"Pancreatoduodenal surgery in patients with multiple endocrine neoplasia type 1: Operative outcomes, long-term function, and quality of life","volume":"142","author":"You","year":"2007","journal-title":"Surgery"},{"issue":"4","key":"10.1016\/j.suc.2024.02.016_bib56","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1097\/00000658-200110000-00009","article-title":"Comparison of surgical results in patients with advanced and limited disease with multiple endocrine neoplasia type 1 and Zollinger-Ellison syndrome","volume":"234","author":"Norton","year":"2001","journal-title":"Ann Surg"},{"issue":"11","key":"10.1016\/j.suc.2024.02.016_bib57","doi-asserted-by":"crossref","first-page":"2856","DOI":"10.1007\/s00268-019-05107-7","article-title":"One-Year Postoperative Mortality in MEN1 Patients Operated on Gastric and Duodenopancreatic Neuroendocrine Tumors: An AFCE and GTE Cohort Study","volume":"43","author":"Christou","year":"2019","journal-title":"World J Surg"},{"issue":"2","key":"10.1016\/j.suc.2024.02.016_bib58","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s12020-017-1234-4","article-title":"Multiple endocrine neoplasia syndrome type 1: institution, management, and data analysis of a nationwide multicenter patient database","volume":"58","author":"Giusti","year":"2017","journal-title":"Endocrine"},{"issue":"2","key":"10.1016\/j.suc.2024.02.016_bib59","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1210\/jcem.87.2.8145","article-title":"Pituitary disease in MEN type 1 (MEN1): data from the France-Belgium MEN1 multicenter study","volume":"87","author":"Verg\u00e8s","year":"2002","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"9","key":"10.1016\/j.suc.2024.02.016_bib60","doi-asserted-by":"crossref","first-page":"3288","DOI":"10.1210\/JC.2015-2015","article-title":"Long-Term Natural Course of Pituitary Tumors in Patients With MEN1: Results From the DutchMEN1 Study Group (DMSG)","volume":"100","author":"de Laat","year":"2015","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.suc.2024.02.016_bib61","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1530\/EJE-12-0763","article-title":"Genetic analysis in young patients with sporadic pituitary macroadenomas: besides AIP don\u2019t forget MEN1 genetic analysis","volume":"168","author":"Cuny","year":"2013","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"10.1016\/j.suc.2024.02.016_bib62","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1111\/j.1399-0004.2010.01406.x","article-title":"The role of germline AIP, MEN1, PRKAR1A, CDKN1B and CDKN2C mutations in causing pituitary adenomas in a large cohort of children, adolescents, and patients with genetic syndromes","volume":"78","author":"Stratakis","year":"2010","journal-title":"Clin Genet"},{"issue":"1","key":"10.1016\/j.suc.2024.02.016_bib63","doi-asserted-by":"crossref","first-page":"78","DOI":"10.7326\/0003-4819-100-1-78","article-title":"Drugs five years later. Bromocriptine","volume":"100","author":"Vance","year":"1984","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.suc.2024.02.016_bib64","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.semcancer.2021.03.035","article-title":"Multiple endocrine neoplasia type 2: A review","volume":"79","author":"Mathiesen","year":"2022","journal-title":"Semin Cancer Biol"},{"issue":"8","key":"10.1016\/j.suc.2024.02.016_bib65","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1210\/js.2018-00178","article-title":"Update on Multiple Endocrine Neoplasia Type 2: Focus on Medullary Thyroid Carcinoma","volume":"2","author":"Raue","year":"2018","journal-title":"J\u00a0Endocr Soc"},{"key":"10.1016\/j.suc.2024.02.016_bib66","doi-asserted-by":"crossref","unstructured":"Dralle H. and Machens A., Syndromic medullary thyroid cancer: MEN 2A and MEN 2B, In: Randolph G.W., Surgery of the thyroid and parathyroid gland, 3rd edition, Elsevier, Inc; Philadelphia, PA, 235\u2013245.","DOI":"10.1016\/B978-0-323-66127-0.00027-2"},{"issue":"6","key":"10.1016\/j.suc.2024.02.016_bib67","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1002\/humu.23430","article-title":"Genotype-specific progression of hereditary medullary thyroid cancer","volume":"39","author":"Machens","year":"2018","journal-title":"Hum Mutat"},{"issue":"6","key":"10.1016\/j.suc.2024.02.016_bib68","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1089\/thy.2014.0335","article-title":"Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma","volume":"25","author":"Wells","year":"2015","journal-title":"Thyroid Off J Am Thyroid Assoc"},{"issue":"7","key":"10.1016\/j.suc.2024.02.016_bib69","doi-asserted-by":"crossref","first-page":"3999","DOI":"10.1210\/jc.2005-0064","article-title":"Codon-specific development of pheochromocytoma in multiple endocrine neoplasia type 2","volume":"90","author":"Machens","year":"2005","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.suc.2024.02.016_bib70","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1097\/SLA.0b013e3182a6f43a","article-title":"Surgical curability of medullary thyroid cancer in multiple endocrine neoplasia 2B: a changing perspective","volume":"259","author":"Brauckhoff","year":"2014","journal-title":"Ann Surg"},{"issue":"1","key":"10.1016\/j.suc.2024.02.016_bib71","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1210\/jc.2017-01884","article-title":"Long-Term Survivorship in Multiple Endocrine Neoplasia Type 2B Diagnosed Before and in the New Millennium","volume":"103","author":"Raue","year":"2018","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"8","key":"10.1016\/j.suc.2024.02.016_bib72","doi-asserted-by":"crossref","first-page":"3149","DOI":"10.1210\/jc.2013-1204","article-title":"Multiple endocrine neoplasia type 2 and familial medullary thyroid carcinoma: an update","volume":"98","author":"Wells","year":"2013","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.suc.2024.02.016_bib73","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/j.surg.2008.08.028","article-title":"Premonitory symptoms preceding metastatic medullary thyroid cancer in MEN 2B: An exploratory analysis","volume":"144","author":"Brauckhoff","year":"2008","journal-title":"Surgery"},{"issue":"3","key":"10.1016\/j.suc.2024.02.016_bib74","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S2213-8587(18)30336-X","article-title":"Natural history, treatment, and long-term follow up of patients with multiple endocrine neoplasia type 2B: an international, multicentre, retrospective study","volume":"7","author":"Castinetti","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"3","key":"10.1016\/j.suc.2024.02.016_bib75","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1093\/jjco\/27.3.128","article-title":"A\u00a0nationwide clinical survey of patients with multiple endocrine neoplasia type 2 and familial medullary thyroid carcinoma in Japan","volume":"27","author":"Iihara","year":"1997","journal-title":"Jpn J Clin Oncol"},{"issue":"4","key":"10.1016\/j.suc.2024.02.016_bib76","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/j.1365-2796.1995.tb01211.x","article-title":"Pheochromocytoma in multiple endocrine neoplasia type 2: European study. The Euromen Study Group","volume":"238","author":"Modigliani","year":"1995","journal-title":"J\u00a0Intern Med"},{"issue":"6","key":"10.1016\/j.suc.2024.02.016_bib77","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1530\/EC-18-0157","article-title":"Incidence and prevalence of sporadic and hereditary MTC in Denmark 1960-2014: a nationwide study","volume":"7","author":"Mathiesen","year":"2018","journal-title":"Endocr Connect"},{"issue":"20","key":"10.1016\/j.suc.2024.02.016_bib78","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1056\/NEJMra0802968","article-title":"Inherited susceptibility to common cancers","volume":"359","author":"Foulkes","year":"2008","journal-title":"N\u00a0Engl J Med"},{"issue":"16","key":"10.1016\/j.suc.2024.02.016_bib79","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1056\/NEJMoa012915","article-title":"Early malignant progression of hereditary medullary thyroid cancer","volume":"349","author":"Machens","year":"2003","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.suc.2024.02.016_bib80","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/978-3-642-84749-3_9","article-title":"Surgical management of MEN 2","volume":"125","author":"Dralle","year":"1992","journal-title":"Recent Results Cancer Res Fortschritte Krebsforsch Progres Dans Rech Sur Cancer"},{"issue":"3\u20134","key":"10.1016\/j.suc.2024.02.016_bib81","first-page":"278","article-title":"Surgical approach of synchronous medullary thyroid carcinoma and pheochromocytoma in MEN 2 syndrome","volume":"40","author":"Scheumann","year":"1992","journal-title":"Henry Ford Hosp Med J"},{"issue":"4","key":"10.1016\/j.suc.2024.02.016_bib82","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1097\/SLA.0000000000001464","article-title":"Management of the Parathyroid Glands During Preventive Thyroidectomy in Patients With Multiple Endocrine Neoplasia Type 2","volume":"262","author":"Moley","year":"2015","journal-title":"Ann Surg"},{"issue":"6","key":"10.1016\/j.suc.2024.02.016_bib83","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1097\/00000658-199806000-00012","article-title":"Effective long-term palliation of symptomatic, incurable metastatic medullary thyroid cancer by operative resection","volume":"227","author":"Chen","year":"1998","journal-title":"Ann Surg"},{"issue":"1","key":"10.1016\/j.suc.2024.02.016_bib84","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1067\/msy.2001.108699","article-title":"Thyroid carcinoma invading the cervicovisceral axis: routes of invasion and clinical implications","volume":"129","author":"Machens","year":"2001","journal-title":"Surgery"},{"issue":"5","key":"10.1016\/j.suc.2024.02.016_bib85","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1007\/s00268-006-0769-y","article-title":"Genotype-phenotype based surgical concept of hereditary medullary thyroid carcinoma","volume":"31","author":"Machens","year":"2007","journal-title":"World J Surg"},{"issue":"2","key":"10.1016\/j.suc.2024.02.016_bib86","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1097\/SLA.0b013e3181ae333f","article-title":"Individualization of lymph node dissection in RET (rearranged during transfection) carriers at risk for medullary thyroid cancer: value of pretherapeutic calcitonin levels","volume":"250","author":"Machens","year":"2009","journal-title":"Ann Surg"},{"issue":"2","key":"10.1016\/j.suc.2024.02.016_bib87","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1210\/jc.2011-2046","article-title":"The timing of total thyroidectomy in RET gene mutation carriers could be personalized and safely planned on the basis of serum calcitonin: 18 years experience at one single center","volume":"97","author":"Elisei","year":"2012","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"12","key":"10.1016\/j.suc.2024.02.016_bib88","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.6004\/jnccn.2018.0089","article-title":"NCCN Guidelines Insights: Thyroid Carcinoma, Version 2.2018","volume":"16","author":"Haddad","year":"2018","journal-title":"J\u00a0Natl Compr Cancer Netw JNCCN"},{"issue":"4","key":"10.1016\/j.suc.2024.02.016_bib89","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1097\/SLA.0b013e31826bc239","article-title":"Benefit-risk balance of reoperation for persistent medullary thyroid cancer","volume":"257","author":"Machens","year":"2013","journal-title":"Ann Surg"},{"issue":"6","key":"10.1016\/j.suc.2024.02.016_bib90","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.surg.2007.09.013","article-title":"Pheochromocytoma penetrance varies by RET mutation in MEN 2A","volume":"142","author":"Quayle","year":"2007","journal-title":"Surgery"},{"issue":"6","key":"10.1016\/j.suc.2024.02.016_bib91","first-page":"1070","article-title":"Prevalence of pheochromocytoma and hyperparathyroidism in multiple endocrine neoplasia type 2A: results of long-term follow-up","volume":"114","author":"Howe","year":"1993","journal-title":"Surgery"},{"issue":"4","key":"10.1016\/j.suc.2024.02.016_bib92","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1002\/jso.23378","article-title":"Pheochromocytoma in an 8-year-old patient with multiple endocrine neoplasia type 2A: implications for screening","volume":"108","author":"Rowland","year":"2013","journal-title":"J\u00a0Surg Oncol"},{"issue":"1","key":"10.1016\/j.suc.2024.02.016_bib93","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1210\/jc.2018-00705","article-title":"Pheochromocytoma in Children and Adolescents With Multiple Endocrine Neoplasia Type 2B","volume":"104","author":"Makri","year":"2019","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"11","key":"10.1016\/j.suc.2024.02.016_bib94","doi-asserted-by":"crossref","first-page":"E1813","DOI":"10.1210\/jc.2013-1653","article-title":"The characterization of pheochromocytoma and its impact on overall survival in multiple endocrine neoplasia type 2","volume":"98","author":"Thosani","year":"2013","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.suc.2024.02.016_bib95","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1097\/00000658-199306000-00001","article-title":"Management of pheochromocytomas in patients with multiple endocrine neoplasia type 2 syndromes","volume":"217","author":"Lairmore","year":"1993","journal-title":"Ann Surg"},{"issue":"10","key":"10.1016\/j.suc.2024.02.016_bib96","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1001\/jamasurg.2022.3544","article-title":"American Association of Endocrine Surgeons Guidelines for Adrenalectomy: Executive Summary","volume":"157","author":"Yip","year":"2022","journal-title":"JAMA Surg"},{"issue":"2","key":"10.1016\/j.suc.2024.02.016_bib97","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.jamcollsurg.2012.10.012","article-title":"Long-term outcomes of surgical treatment for hereditary pheochromocytoma","volume":"216","author":"Grubbs","year":"2013","journal-title":"J\u00a0Am Coll Surg"},{"issue":"12","key":"10.1016\/j.suc.2024.02.016_bib98","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1001\/archsurg.141.12.1199","article-title":"Estimated risk of pheochromocytoma recurrence after adrenal-sparing surgery in patients with multiple endocrine neoplasia type 2A","volume":"141","author":"Asari","year":"2006","journal-title":"Arch Surg"},{"issue":"8","key":"10.1016\/j.suc.2024.02.016_bib99","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.8898","article-title":"Comparison of Pheochromocytoma-Specific Morbidity and Mortality Among Adults With Bilateral Pheochromocytomas Undergoing Total Adrenalectomy vs Cortical-Sparing Adrenalectomy","volume":"2","author":"Neumann","year":"2019","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.suc.2024.02.016_bib100","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/978-3-319-22542-5_8","article-title":"Primary Hyperparathyroidism in MEN2 Syndromes","volume":"204","author":"Alevizaki","year":"2015","journal-title":"Recent Results Cancer Res Fortschritte Krebsforsch Progres Dans Rech Sur Cancer"},{"issue":"5","key":"10.1016\/j.suc.2024.02.016_bib101","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/j.suc.2009.06.016","article-title":"Surgical management of MEN-1 and -2: state of the art","volume":"89","author":"Akerstr\u00f6m","year":"2009","journal-title":"Surg Clin North Am"},{"issue":"4","key":"10.1016\/j.suc.2024.02.016_bib102","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/j.1365-2796.1995.tb01212.x","article-title":"Primary hyperparathyroidism in multiple endocrine neoplasia type 2A","volume":"238","author":"Raue","year":"1995","journal-title":"J\u00a0Intern Med"},{"issue":"7","key":"10.1016\/j.suc.2024.02.016_bib103","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1007\/s002689900123","article-title":"Primary hyperparathyroidism in multiple endocrine neoplasia type IIa: retrospective French multicentric study. Groupe d\u2019Etude des Tumeurs \u00e1 Calcitonine (GETC, French Calcitonin Tumors Study Group), French Association of Endocrine Surgeons","volume":"20","author":"Kraimps","year":"1996","journal-title":"World J Surg"},{"issue":"5","key":"10.1016\/j.suc.2024.02.016_bib104","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1007\/s00268-006-0907-6","article-title":"Central lymph node dissection in differentiated thyroid cancer","volume":"31","author":"White","year":"2007","journal-title":"World J Surg"},{"issue":"1","key":"10.1016\/j.suc.2024.02.016_bib105","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1097\/CCO.0b013e328333ac97","article-title":"Controversy surrounding the role for routine central lymph node dissection for differentiated thyroid cancer","volume":"22","author":"Carling","year":"2010","journal-title":"Curr Opin Oncol"},{"issue":"6","key":"10.1016\/j.suc.2024.02.016_bib106","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1016\/S0039-6060(96)80042-0","article-title":"Surgical management of hyperparathyroidism in patients with multiple endocrine neoplasia type 2A","volume":"120","author":"Herfarth","year":"1996","journal-title":"Surgery"}],"container-title":["Surgical Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S003961092400032X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S003961092400032X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,28]],"date-time":"2024-06-28T06:35:04Z","timestamp":1719556504000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S003961092400032X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":106,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["S003961092400032X"],"URL":"https:\/\/doi.org\/10.1016\/j.suc.2024.02.016","relation":{},"ISSN":["0039-6109"],"issn-type":[{"value":"0039-6109","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation and Surgical Management of Multiple Endocrine Neoplasias","name":"articletitle","label":"Article Title"},{"value":"Surgical Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.suc.2024.02.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}